Trade OVID anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Ovid Therapeutics Inc. (OVID) is trading at US$2.82, down 3.92% today as of Aug 28, 13:32 EDT. The company has a market capitalisation of US$546.83M. Over the past 52 weeks, OVID has traded between US$1.12 and US$3.11. On Syfe you can trade OVID with $0 commission and add it to your watchlist.
| Previous close | US$2.93 |
|---|---|
| Market cap | US$546.83M |
| 52-week range | US$1.12 – US$3.11 |
| Volume | 1.72M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Ovid Therapeutics Inc.
Ovid Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering better, gentler medicines for the brain. It discovers and develops differentiated, small molecule medicines for neurological and neuropsychiatric disorders with significant unmet need. The company was founded by Matthew During and Jeremy M. Levin on April 1, 2014 and is headquartered in New York, NY.
Year: 2017
Ovid Therapeutics Names Kevin Norrett Chief Business Officer, Promotes CFO and Chief Strategy Officer
Jul 8, 11:52 AM · MT Newswires
Wedbush Raises Price Target on Ovid Therapeutics to $7 From $5, Keeps Outperform Rating
Mar 19, 11:58 AM · MT Newswires
Exchange-Traded Funds, Equity Futures Lower Ahead of Key Economic Data, FOMC Meeting
Mar 18, 1:28 PM · MT Newswires
Sector Update: Health Care Stocks Decline Premarket Wednesday
Mar 18, 1:16 PM · MT Newswires
Ovid Therapeutics Inc. (OVID) stock is trading at US$2.82, -3.92% from the previous close of US$2.93.
The market cap for Ovid Therapeutics Inc. (OVID) stock is approximately US$546.83M.
The 52-week high for Ovid Therapeutics Inc. (OVID) stock is US$3.11.
The 52-week low for Ovid Therapeutics Inc. (OVID) stock is US$1.12.
Ovid Therapeutics Inc. (OVID) does not currently pay a dividend.
Stay on top of OVID
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
